Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors

NCT00193570 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

DRUG: Topotecan
DRUG: Docetaxel

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]
[object Object]